OtherPublishAheadOfPrint
Radioimmunotherapy in Non-Hodgkin Lymphoma: Opinions of U.S. Medical Oncologists and Hematologists
Niklaus G. Schaefer, Jiemin Ma, Peng Huang, Judy Buchanan and Richard L. Wahl
Journal of Nuclear Medicine May 2010, DOI: https://doi.org/10.2967/jnumed.109.073155
Niklaus G. Schaefer
Jiemin Ma
Peng Huang
Judy Buchanan
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Radioimmunotherapy in Non-Hodgkin Lymphoma: Opinions of U.S. Medical Oncologists and Hematologists
Niklaus G. Schaefer, Jiemin Ma, Peng Huang, Judy Buchanan, Richard L. Wahl
Journal of Nuclear Medicine May 2010, DOI: 10.2967/jnumed.109.073155
Jump to section
Related Articles
Cited By...
- Current Landscape in Clinical Pretargeted Radioimmunoimaging and Therapy
- Proceedings of the Second NCI-SNMMI Workshop on Targeted Radionuclide Therapy
- Advances in the treatment of hematologic malignancies using immunoconjugates
- Targeted Radionuclide Therapy: Proceedings of a Joint Workshop Hosted by the National Cancer Institute and the Society of Nuclear Medicine and Molecular Imaging
- Radioimmunotherapy in Non-Hodgkin Lymphoma: Opinions of Nuclear Medicine Physicians and Radiation Oncologists
- Radioimmunotherapy of relapsed indolent non-Hodgkin lymphoma with 131I-rituximab in routine clinical practice: 10-year single-institution experience of 142 consecutive patients